↓ Skip to main content

A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies

Overview of attention for article published in BMC Cancer, March 2013
Altmetric Badge

Citations

dimensions_citation
99 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies
Published in
BMC Cancer, March 2013
DOI 10.1186/1471-2407-13-152
Pubmed ID
Authors

Jonathan W Goldman, Robert N Raju, Gregory A Gordon, Iman El-Hariry, Florentina Teofilivici, Vojo M Vukovic, Robert Bradley, Michael D Karol, Yu Chen, Wei Guo, Takayo Inoue, Lee S Rosen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 20%
Student > Ph. D. Student 10 19%
Student > Doctoral Student 6 11%
Researcher 6 11%
Student > Master 6 11%
Other 8 15%
Unknown 7 13%
Readers by discipline Count As %
Medicine and Dentistry 12 22%
Agricultural and Biological Sciences 11 20%
Biochemistry, Genetics and Molecular Biology 8 15%
Chemistry 4 7%
Nursing and Health Professions 3 6%
Other 9 17%
Unknown 7 13%